Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.979
+0.008 (0.78%)
Jan 17, 2025, 4:00 PM EST - Market closed
Hyperfine Revenue
Hyperfine had revenue of $3.64M in the quarter ending September 30, 2024, with 56.35% growth. This brings the company's revenue in the last twelve months to $13.26M, up 35.67% year-over-year. In the year 2023, Hyperfine had annual revenue of $11.03M with 61.90% growth.
Revenue (ttm)
$13.26M
Revenue Growth
+35.67%
P/S Ratio
5.33
Revenue / Employee
$101,183
Employees
131
Market Cap
71.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 11.03M | 4.22M | 61.90% |
Dec 31, 2022 | 6.81M | 5.32M | 355.48% |
Dec 31, 2021 | 1.50M | 1.20M | 408.84% |
Dec 31, 2020 | 294.00K | - | - |
Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
HYPR News
- 4 weeks ago - Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets - Business Wire
- 6 weeks ago - Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care - Business Wire
- 6 weeks ago - Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals - Business Wire
- 2 months ago - Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body - Business Wire
- 2 months ago - Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings - Business Wire
- 2 months ago - Hyperfine, Inc. to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Hyperfine, Inc. Reports Third Quarter 2024 Financial Results - GlobeNewsWire